K.V. Vovk, E.Y. Nikolenko, N.K. Alexandrova, O.V. Sokruto, L.K. Ovcharenko

THE INFLUENCE OF CHRONIC NON–CALCULOUS CHOLECYSTITIS ON THE COURSE OF CORONARY HEART DISEASE

---

About the author:	K.V. Vovk, E.Y. Nikolenko, N.K. Alexandrova, O.V. Sokruto, L.K. Ovcharenko
Heading	CLINICAL MEDICINE
Type of article	Scentific article
Annotation	Diseases of the gallbladder and biliary ducts, particularly, chronic non–calculous cholecystitis is a common pathology of internal organs. In addition, with chronic non-calculous cholecystitis, a reflex disorder of the coronary blood circulation, metabolic and autoimmune dystrophic lesions of the myocardium and its conduction system, which can affect the contractile function and heart rhythm, are found. Significant prevalence of these two diseases, high level of work incapacity and disability determine the relevance of the problem of the combined course of these diseases. The purpose of the work was to determine the characteristics of the course of coronary heart disease with concomitant chronic non–calculous cholecystitis, taking into account the functional state of the cardiovascular system. The total of 88 patients who were on outpatient treatment was examined. The clinical course of stable effort angina of functional classes I and II with concomitant chronic non–calculous cholecystitis is characterized by more pronounced clinical manifestations of cardiac pathology, an increase in resistance to drug treatment, and a decrease in exercise tolerance. Coronary heart disease without hronic non–calculous cholecystitis occurs as an independent disease and is not accompanied by changes in the biliary system. Lipid peroxidation enhancement plays a role in increasing the clinical manifestation of coronary heart disease with concomitant inflammation of the gallbladder. Complication of the clinical course of coronary heart disease with simultaneous chronic non–calculous cholecystitis correlates with more pronounced atherogenic lipid metabolism, activation of lipid peroxidation processes and antioxidant protection deficiency in the blood, impaired hemostasis and inhibition of the heart contractile function. Chronic non-calculous cholecystitis significantly complicates the course of coronary artery disease with stable angina of functional classes I–II: more pronounced changes in the lipid spectrum, indicating the rapid development of atherosclerosis, combination of pain in the heart and right hypochondrium, severe dyspeptic syndrome.
Tags	coronary heart disease, chronic non–calculous cholecystitis, lipid peroxidation, stable angina, antioxidant protection
Bibliography	Bazylevych AYa. Osoblyvosti perebihu ishemichnoyi khvoroby sertsya u poyednanni z nealkoholnoyu zhyrovoyu khvoroboyu pechinky: mekhanizmy formuvannya, diahnostyka, optymizatsiya likuvannya, prohnoz. [dysertatsiya] Lviv; 2011. 30s. [in Ukrainian] Grigoryeva IN. Osnovnyye faktory riska zhelchnokamennoy bolezni. Rossiyskiy zhurnal gastroenterolohiyi, gepatolohiyi, koloproktolohiyi. 2010; 17(6): 17–21. [in Russian] Polunina TE, Mayev IV. Nealkogolnaya zhirovaya bolezn pecheni: epidemiologiya, patogenez, diagnostika, lecheniye. Cosilium medicum. Gastroenterologiya. 2012; 1:35–40. [in Russian] Balmadrid B.  Recent advances  in management of acalculous cholecystitis.  F1000 Faculty Rev-1660. –  2018 Oct 18;7: doi: 10.12688/f1000research. Swift DL, Johannsen NM, Lavie CJ, Earnest CP, Church TS.  The role of exercise and physical activity in weight loss and maintenance. Prog Cardiovasc Dis.– 2014 Jan-Feb;56(4):441–7. doi: 10.1016/j.pcad.2013.09.012. Assy N, Djibre A, Farah R. Presence of coronary plaques in patients with non-alcoholic fatty liver disease. Radiology. 2010; 254(2): 393–400. Lavoie B, Nausch B, Zane EA, Leonard MR, Balemba OB, Bartoo AC, Wilcox R, Nelson MT, Carey MC, Mawe GM. Disruption of gallbladder smooth muscle function is an early feature in the development of cholesterol gallstone disease. Neurogastroenterol Motil2012; 24: e313–e324. doi: 10.1111/j.1365-2982.2012.01935. Sisakian H, Kocharyan A. Non-alcoholic fatty liver disease as risk of cardiovascular disease: myth or reality? Int. J. Cardiol. Lipidol. Res. 2016; 3: 20–24. Souza MR, Dinizude F, Medeiros- Filho JE, Araujo MS. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arg. Gastroenterol. 2012; 49(1): 89–96. Stewart AHR, Held C, Hadziosmanovic N, Armstrong PW. Physical activity and mortality in patients with stable coronary heart disease.J    Am Coll Cardiol. 2017 Oct 3; 70(14):1689–1700. doi: 10.1016/j.jacc.2017.08.017. Tahergorabi Z, Khazaei M. Leptin and its cardiovascular effects: Focus on angiogenesis. Adv. Biomed. Res. Available at: 2016; URL: http: // www. advbiores. net. Wang CC, Tseng TC, Hsieh TC. Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk. Kaohsiung J. Med. Sci. 2012; 28(3): 151–160.
Publication of the article	«World of Medicine and Biology» №4(74), 2020 year, 20-23 pages, index UDK 616.12–005.4:616.366 – 002] – 092 – 085
DOI	10.26724/2079-8334-2020-4-74-20-23